Literature DB >> 27167628

RE: Effects of adjuvant chemotherapy on recurrence, survival and quality of life in stage II colon cancer patients: a 24-month follow-up.

F N van Erning1,2, P A J Vissers3, C J A Punt4, V E P P Lemmens3,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27167628     DOI： 10.1007/s00520-016-3267-2

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  6 in total

Review 1.  Competing risks in epidemiology: possibilities and pitfalls.

Authors:  Per Kragh Andersen; Ronald B Geskus; Theo de Witte; Hein Putter
Journal:  Int J Epidemiol       Date:  2012-01-09       Impact factor: 7.196

2.  Population-based study of prognostic factors in stage II colonic cancer.

Authors:  M Morris; C Platell; B de Boer; K McCaul; B Iacopetta
Journal:  Br J Surg       Date:  2006-07       Impact factor: 6.939

3.  Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer.

Authors:  S R Verhoeff; F N van Erning; V E P P Lemmens; J H W de Wilt; J F M Pruijt
Journal:  Int J Cancer       Date:  2016-03-12       Impact factor: 7.396

Review 4.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

Authors:  Al B Benson; Deborah Schrag; Mark R Somerfield; Alfred M Cohen; Alvaro T Figueredo; Patrick J Flynn; Monika K Krzyzanowska; Jean Maroun; Pamela McAllister; Eric Van Cutsem; Melissa Brouwers; Manya Charette; Daniel G Haller
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

5.  Effects of adjuvant chemotherapy on recurrence, survival, and quality of life in stage II colon cancer patients: a 24-month follow-up.

Authors:  Cari Lewis; Pengcheng Xun; Ka He
Journal:  Support Care Cancer       Date:  2015-09-09       Impact factor: 3.603

6.  A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer.

Authors:  Elinor Bexe Lindskog; Katrín Ásta Gunnarsdóttir; Kristoffer Derwinger; Yvonne Wettergren; Bengt Glimelius; Karl Kodeda
Journal:  BMC Cancer       Date:  2014-12-13       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.